NBIX
Neurocrine BiosciencesANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
NBIX vs peer average
76/100
NBIX vs. peer average (A vs. C)
Grade spread
A 2 · B 3 · C 3 · D 1 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ACAD is the first available peer comparator.
Direct CNS commercial comparator from the prior baseline; useful for framing specialty-neurology execution and payer access, though it is not in the packet's current peer-candidate list.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NBIX
Neurocrine Biosciences
ACAD
ACADIA
Grade
A
C
Momentum
88
27
Value
62
62
Sentiment
61
75
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs ACAD
NBIX / ACAD
Grade Position
Above peers
NBIX vs. peer average (A vs. C)
76/100
Momentum
88
NBIXValue
62
ACADSentiment
61
ACADRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NBIX
ACAD is the first peer returned for this comparison set.